Breaks Categories: News

ThursdayNov 30, 2023 10:32 am

NetworkNewsBreaks — SenesTech Inc. (NASDAQ: SNES) Closes on Public Offering Resulting in Gross Proceeds of $5M

SenesTech (NASDAQ: SNES), the leader in fertility control to manage animal pest populations, has closed on its previously announced public offering. According to the announcement, the offering was comprised of 3,846,154 shares of its common stock (or prefunded warrants in lieu thereof) and accompanying Series D warrants to purchase up to 3,846,154 shares of its common stock (Series D warrants) and Series E warrants to purchase up to 3,846,154 shares of its common stock (Series E warrants, together with Series D warrants, collectively the series warrants); the shares were offered at a combined offering price of $1.30 per share. The announcement noted…

Continue Reading

WednesdayNov 29, 2023 2:24 pm

NetworkNewsBreaks – Tharimmune Inc. (NASDAQ: THAR) Announces Pricing of $10M Public Offering

Tharimmune (NASDAQ: THAR), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for rare, inflammatory and oncologic conditions, has announced the pricing of an underwritten public offering of 10,000,000 shares of common stock (or pre-funded warrants in lieu thereof). Each share of common stock (or pre-funded warrant) is being sold at a public offering price of $1.00 per share (inclusive of the pre-funded warrant exercise price) for gross proceeds to Tharimmune of $10,000,000. All of the shares of common stock and pre-funded warrants are being offered by the company. In addition, Tharimmune granted the underwriters a 45-day option to…

Continue Reading

WednesdayNov 29, 2023 2:19 pm

NetworkNewsBreaks – Branded Legacy Inc. (BLEG) Commences Buyback of 1M Preferred Class D Shares

Branded Legacy (OTC: BLEG), a pioneer in the biotechnology and wellness industries, announced its strategic decision to buy back and retire 1,000,000 Preferred Class D Shares. The significant move protects against a conversion ratio of 1 Preferred Class D Share to 100 Common Unrestricted shares, marking a pivotal step in enhancing shareholder value and simplifying Branded Legacy’s share structure by preventing these shares from entering the market. “The buyback and retirement of these Preferred Class D Shares is a strategic move to reinforce our shareholders’ value by preventing dilution,” said Branded Legacy CEO David Oswald. “We are committed to enhancing…

Continue Reading

WednesdayNov 29, 2023 1:36 pm

NetworkNewsBreaks – Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) Announces Maturity Extension of EIB Finance Facility

Scinai Immunotherapeutics (NASDAQ: SCNI) today announced the execution of a formal amendment to its finance contract with the European Investment Bank (“EIB”). According to the announcement, the amendment extends the maturity date of the contract by four years from Dec. 31, 2027, to Dec. 31, 2031. “I thank the EIB for their ongoing support and cooperation. As the lending arm of the European Union, the EIB’s mission includes providing financing to support medical research and improve health care, and to do so in a manner that provides innovative young companies not only with required resources but also sufficient time to…

Continue Reading

WednesdayNov 29, 2023 1:22 pm

NetworkNewsBreaks – Sekur Private Data Ltd. (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) Enters Strategic Distribution Agreement in Qatar

Sekur Private Data (CSE: SKUR) (OTCQB: SWISF) (FSE: GDT0) today announced that it has signed an agreement with a distributor in the State of Qatar (“Qatar”) in order to distribute its entire Sekur Swiss-hosted private and encrypted communications platform. The agreement was signed with Beyond Limits Programs and Electronics (“BLPE”), a Qatari corporation from Doha, Qatar, and is valid for 12 months with renewal options for an additional 12 months. “We are thrilled to have signed this distribution agreement for Qatar and BLPE. Mr. Talal Hassoun, CEO of BLPE, has over 20 years of experience in enterprise software sales in…

Continue Reading

WednesdayNov 29, 2023 1:11 pm

NetworkNewsBreaks — Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Announces Updated Target Discovery Area Size

Appia Rare Earths & Uranium (CSE: API) (OTCQX: APAAF) (FSE: A0I0), a publicly traded Canadian company in the rare earth element and uranium sectors, has announced updated numbers regarding an unprecedented high-grade mineralized zone discovery at its PCH Ionic Clay project in Brazil. According to the announcement, the discovery indicated a total weighted average grade of 7,578 ppm or 0.76% total rare earth oxide across 10 reverse circulation (“RC”) drill holes. The updated numbers reflect that Target IV has been updated to 193 hectares, rather than the 1,702 hectares previously announced. “Appia's work with exploratory auger drilling has delivered compelling results,…

Continue Reading

TuesdayNov 28, 2023 1:46 pm

NetworkNewsBreaks – Astra Energy Inc. (ASRE) Announces Engagement of RICO and Securities Litigation Attorney Mark R. Basile, Esq. and The Basile Law Firm P.C.

Astra Energy (OTCQB: ASRE) today announced that it has retained toxic dilution funding expert attorney Mark R. Basile, Esq. and his RICO and securities litigation firm, The Basile Law Firm P.C. According to the announcement, the services to be provided include investigating recent activities surrounding the company’s stock performance and any potential RICO and Securities violations claims for all fundings taken by prior management over the last four years. “We are pleased to welcome Mr. Basile and his law firm, The Basile Law Firm P.C., to investigate claims of potential naked short selling of our security in connection to any…

Continue Reading

TuesdayNov 28, 2023 1:05 pm

NetworkNewsBreaks – UBet Sports Onboarding Solution for Web2 Bettors Is ‘Reshaping’ Decentralized Web3 Landscape

UBet Sports, a decentralized sportsbook, is announcing a solution to onboarding traditional Web2 bettors into a Web3 environment. According to the announcement, UBET Sports was the first on-chain sportsbook to provide answers to the challenges associated with integrating Web2 users onto a decentralized Web3 platform. This focus was identified by UBET Sports as it recognized the importance of simple and intuitive onboarding and making accessibility a priority. As a result, accessibility is a core component of its decentralized Web3 applications. With this in mind, the UBET Sports onboarding experience is reshaping the decentralized gaming landscape with a commitment to user-friendly…

Continue Reading

TuesdayNov 28, 2023 12:25 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) Issues update on GBB Drink Lab Inc. Litigation and Safety Shot

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA:0K9A) is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions. The company has issued a statement as an update regarding its litigation with GBB Drink Lab Inc. previously referenced at: FSD Pharma Rebuts Claims of GBB Drink Lab now acquired by Jupiter Wellness Inc. (NASDAQ: JUPW). In May of this year, GBB filed a lawsuit against FSD Pharma alleging a material breach of a mutual nondisclosure agreement and trade secret misappropriation. FSD Pharma has categorically denied these allegations and filed a motion to dismiss the lawsuit, which is…

Continue Reading

TuesdayNov 28, 2023 11:50 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary Tech Lowers Blood Glucose More Effectively than Branded GLP-1 drug Semaglutide Alone, Study Shows

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting additional positive interim results from its human pilot study evaluating DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially as Rybelsus(R). According to the report, DehydraTECH-powered semaglutide sustained lower levels of blood glucose from baseline including nearly 10 times lower after 24 hours as well as lower blood-glucose spikes after eating. The company noted that this was the first-ever DehydraTECH test with a “large molecule” drug. According to the report, the study was conducted by a prominent university research center comparing a single…

Continue Reading